SCHEMBL2082809

SCHEMBL2082809

CC1(S)CCCCOC1=O

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2080450 0.93
SCHEMBL2082188 0.84
SCHEMBL430902 0.79 CA1 (0.39) CA1CA9LMNACYP2C9
SCHEMBL5574508 0.77 CA1 (0.37) CA1CA9
SCHEMBL14343521 0.77 CA1 (0.37) CA1CA9LMNACYP2C9
SCHEMBL11582583 0.77 CA1 (0.37) CA1CA9LMNACYP2C9
SCHEMBL28370287 0.72 CA1 (0.33) CA1CA9LMNACYP2C9
SCHEMBL441725 0.72
SCHEMBL7112607 0.72 CA1 (0.40) CA1CA9LMNA
SCHEMBL576317 0.71 TSHR (0.35) CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250296918-A1 METHOD FOR PRODUCING MERCAPTO HETEROCYCLIC COMPOUND AND METHOD FOR TESTING THE SAME RESONAC CORPORATION (JP) 2025-09-25 US disclosed
WO-2023210608-A1 PRODUCTION METHOD AND TEST METHOD FOR MERCAPTO HETEROCYCLIC COMPOUND 株式会社レゾナック 2023-11-02 WO disclosed
WO-2015198923-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2015-12-30 WO disclosed
US-8961946-B2 Hair processing agent and method for permanent waving hair SHOWA DENKO K.K. (JP) 2015-02-24 US disclosed
EP-2024330-B1 PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND SHOWA DENKO KK (JP) 2012-04-25 EP disclosed
US-7902383-B2 Production method of heterocyclic mercapto compound SHOWA DENKO K.K. (JP) 2011-03-08 US disclosed
EP-1896139-B1 PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT SHOWA DENKO KK (JP) 2010-03-31 EP disclosed
US-20090171095-A1 PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND SHOWA DENKO K.K. (JP) 2009-07-02 US disclosed
US-20090081147-A1 PERMANENT WAVING AGENT SHOWA DENKO K.K. (JP) 2009-03-26 US disclosed
EP-2024330-A1 PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND Showa Denko K.K. (JP) 2009-02-18 EP disclosed
US-20080131389-A1 Hair Relaxer SHOWA DENKO K.K. (JP) 2008-06-05 US disclosed
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; RESONAC CORPORATION (JP) 2008-04-10 US disclosed
EP-1896139-A2 PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT Showa Denko K.K. (JP) 2008-03-12 EP disclosed
WO-2007139215-A1 PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND SHOWA DENKO K.K. (JP) 2007-12-06 WO disclosed
EP-1845940-A1 HAIR RELAXER Showa Denko K.K. (JP) 2007-10-24 EP disclosed
EP-1827370-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR Showa Denko K.K. (JP) 2007-09-05 EP disclosed
WO-2006121214-A2 PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT SHOWA DENKO K.K. (JP) 2006-11-16 WO disclosed
WO-2006083031-A1 HAIR RELAXER SHOWA DENKO K.K. (JP) 2006-08-10 WO disclosed
WO-2006068276-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR SHOWA DENKO K.K. (JP) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080131389-A1 Hair Relaxer BHMT2, BHMT, MGMT CA1 852/4885CA9 1082/4885LMNA 2550/4885
US-20250296918-A1 METHOD FOR PRODUCING MERCAPTO HETEROCYCLIC COMPOUND AND METHOD FOR TESTING THE SAME MPST, TST, DHPS CA1 810/4885CA9 461/4885LMNA 3847/4885
US-20090081147-A1 PERMANENT WAVING AGENT SULT2A1, SULT1A1, CYP2F1 CA1 694/4885CA9 2015/4885LMNA 3929/4885
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; TST, CYSLTR1, CYSLTR2 CA1 326/4885CA9 1716/4885LMNA 4594/4885
US-20090171095-A1 PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND POR, SULT2A1, CYP2E1 CA1 786/4885CA9 3224/4885LMNA 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.